Oppenheimer Reiterates Outperform Rating on Immuneering Corporation (IMRX) following Q4
Tweet Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $30.00 price target on Immuneering Corporation (NASDAQ: IMRX)The analyst commented, "IMRX's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
